Skip to nav Skip to content

News

Facebook Twitter LinkedIn Email

HIVMA Urges Adoption of New Statin Therapy Recommendations for People With HIV

People with HIV have about a two-fold increased risk of cardiovascular disease and develop the disease about a decade earlier than the general population.

HIVMA Chair Applauds Appointment of Robyn Neblett Fanfair, MD, MPH, as Director of HIV Prevention at CDC

HIVMA is excited to congratulate Robyn Neblett Fanfair, MD, MPH, on her appointment as the permanent director of the Centers for Disease Control and Prevention’s Division of HIV Prevention.

IDSA & HIVMA on the Passing of ID & HIV Leader Adaora Adimora, MD, MPH, FIDSA

Dr. Adaora Adimora exemplified the difference a single person can make in the world. She was an extraordinary leader, infectious diseases physician, researcher, mentor, advocate and colleague committed to addressing the drivers of HIV-related health disparities with a special focus on women.

Response to Increase in Syphilis Cases in the United States

The dramatic increase in cases — 755% between 2012 and 2021 — represents missed opportunities in the health care system and the need for more resources at the local, state and federal levels.

HIVMA Recognizes Excellence in HIV Clinical Education and Research With 2023 Awards

The HIV Medicine Association is pleased to recognize three members during IDWeek 2023 for their contributions to advancing the field of HIV medicine.

HIVMA Names Allison Agwu Chair of its Board of Directors

The HIV Medicine Association is pleased to announce Allison Agwu, MD, ScM, FAAP, FIDSA, as its new chair. The Association also elected a new vice chair and named five new directors. HIVMA addresses health disparities and inequities in its mission to end the HIV epidemic. 

IDSA and HIVMA on Updated PrEP Recommendations

The Infectious Diseases Society of America and the HIV Medicine Association welcome the U.S. Preventive Services Task Force’s updated statement reaffirming and expanding its Grade A recommendation for pre-exposure prophylaxis for the prevention of HIV among adolescents and adults.

Senate Appropriations Bill Misses Opportunity to Fund Workforce Pilot Program

The Senate’s FY 2024 Labor, Health and Human Services and State and Foreign Operations appropriations bills largely flat fund ID programs at FY 2023 levels and provide a few modest increases.

House Appropriations Bills Endanger Domestic and Global ID Programs

IDSA is disappointed that the House Labor, Health and Human Services Subcommittee did not fund the Bio-Preparedness Workforce Pilot Program in its FY 2024 appropriations bill, missing an opportunity to close the widening ID workforce gap.

IDSA and HIVMA on Incoming NIAID Director Dr. Jeanne Marrazzo

Dr. Marrazzo is an exceptional infectious diseases physician, leader, mentor and scientist who has dedicated her career to key areas of research, including sexually transmitted infections, HIV and antimicrobial resistance.

Congress Must Sustain HIV Research and Prevention Funding

Scientific Advances in HIV Signal Need for Continued Investment

Breakthrough research presented at the International AIDS Society’s 2023 Conference on HIV Science in Brisbane, Australia this week demonstrates the significant advances and scientific achievements recently made in HIV science.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.